Tag: HEA MTC BIO MEQ PHA

Everads Announces Two Oral Presentations at ASRS 2025, Including Full Clinical Trial Results with Its Novel Suprachoroidal Injector

– Clinical study confirms safety, feasibility, and tolerability of the Everads Injector– – Preclinical data demonstrate the feasibility of in-office, minimally invasive suprachoroidal buckling using...

- A word from our sponsors -

Newsletter Signup

Name(Required)

First Last

Email(Required)

Enter Email Confirm Email

CAPTCHA

Privacy(Required)

I agree with the storage and handling of my data by this website. - Privacy Policy *

Name

This field is for validation purposes and should be left unchanged.

HomeTagsHEA MTC BIO MEQ PHA

Vincere Portfolios Reports Six Years of Audited Algorithm Performance as Demand Grows for Systematic Investing Solutions

Booking Health Announces Release of Findings on International Access to Personalized Glioblastoma Treatment in Germany

In HelloNation, HVAC Expert Anthony Lane Explains What to Do When an Air Conditioner Stops Working

Tag: HEA MTC BIO MEQ PHA

Everads Announces Two Oral Presentations at ASRS 2025, Including Full Clinical Trial Results with Its Novel Suprachoroidal Injector

Newsletter Signup

Explore

Press Releases

News & Opinion

Living

Others

Follow us